CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
ADCendo
ADCendo logo

ADCendo

Clinical-stage ADC oncology biotech advancing three tumor-selective programs for high-unmet-need cancers.

Frederiksberg, DK🇩🇰
Founded
2017
Overview
Compare
Fundraising
Employees
News
Library

Adcendo ApS develops antibody-drug conjugates that pair tumor-selective monoclonal antibodies with topoisomerase-I linker-payload combinations. Its pipeline holds ADCE-T02 directed at tissue factor, ADCE-D01 directed at uPARAP, and ADCE-B05 directed at an undisclosed target, each in Phase 1 development.

ADCE-T02 uses an optimized antibody designed to avoid interference with the coagulation pathway, unlike the first-generation tissue factor conjugate. ADCE-D01 addresses mesenchymal cancers including soft tissue sarcoma through uPARAP, a rapidly internalizing endocytic receptor with differentiated expression between tumor and healthy tissue.

ADCendo - Similar Companies

Accenta logo

Accenta

accenta.ai

SemiDrive logo

SemiDrive

semidrive.com

Accro Bioscience logo

Accro Bioscience

accropeutics.com

ABK Biomedical logo

ADCendo - Quick Facts

Who are ADCendo's competitors?

Companies similar to ADCendo include Accenta, SemiDrive, Accro Bioscience and ABK Biomedical.

When was ADCendo founded?

ADCendo was founded in 2017.

Where is ADCendo's headquarters located?

ADCendo's headquarters is located in Frederiksberg, DK.

When was ADCendo's last funding round?

ADCendo's most recent funding round was for $75M (USD) in April 2026.

How much disclosed funding has ADCendo raised?

As of Apr 1, 2026, ADCendo has disclosed funding of $322M (USD). Undisclosed round amounts are excluded.

ADCendo - Classification

Ownership
  • Venture-backed

ABK Biomedical

abkbiomedical.com

Accession Therapeutics logo

Accession Therapeutics

smallcase logo

smallcase

smallcase.com

Abiochem Biotechnology logo

Abiochem Biotechnology

abiochem.cn

Hangzhou DAC Biotech Co., Ltd logo

Hangzhou DAC Biotech Co., Ltd

dacbiotech.com

Dexory logo

Dexory

dexory.com

Solfácil logo

Solfácil

solfacil.com.br

Vertero logo

Vertero

vertero.com

Riiid logo

Riiid

riiid.com

TenX logo

TenX

tenx.tech

Micronano Core logo

Micronano Core

nanocorechip.com

Anocca logo

Anocca

anocca.com